Cognitive Change

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Plus Therapeutics
1 program
Juice PLUS+® OMEGAN/A1 trial
Active Trials
NCT05581108CompletedEst. Jul 2023
UP
UCB PharmaBelgium - Brussels
1 program
cognitive rehabilitationN/A1 trial
Active Trials
NCT05057156Unknown90Est. Mar 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Plus TherapeuticsJuice PLUS+® OMEGA
UCB Pharmacognitive rehabilitation

Clinical Trials (2)

Total enrollment: 90 patients across 2 trials

NCT05581108Plus TherapeuticsJuice PLUS+® OMEGA

Enhancement of Learning and Memory Following Supplementation With Juice PLUS+® OMEGA in an Adolescent Population

Start: Oct 2021Est. completion: Jul 2023
N/ACompleted
NCT05057156UCB Pharmacognitive rehabilitation

Digital Solution to Improve Cognitive Function in Epilepsy: PRODDIGE Project

Start: Oct 2021Est. completion: Mar 202490 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space